Selected research
Industry Research
Orthobiologics Industry Research Report 2026
Market perspective
The global Orthobiologics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Orthobiologics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Orthobiologics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Orthobiologics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Orthobiologics include Stryker Corporation, Sanofi-Aventis (Sanofi SA), Medtronic, Zimmer Biomet Holdings, TRB Chemedica International SA, Seikagaku Corporation, SeaSpine Holdings Corporation, RTI Surgical, Inc. and Orthofix International N.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Orthobiologics market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Orthobiologics Market by Company
Stryker Corporation
Sanofi-Aventis (Sanofi SA)
Medtronic
Zimmer Biomet Holdings
TRB Chemedica International SA
Seikagaku Corporation
SeaSpine Holdings Corporation
RTI Surgical, Inc.
Orthofix International N.V.
NuVasive, Inc.
Musculoskeletal Transplant Foundation, Inc.
Ito
Heraeus Holding GmbH
Fidia Pharma USA Inc.
Djo Global, Inc.
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex, Inc.
Anika Therapeutics, Inc.
Allosource
Orthobiologics Segment by Type
Viscosupplements
Bone Graft Substitute
Bone Growth Stimulators (BGS)
Orthobiologics Segment by Application
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics
Orthobiologics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthobiologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orthobiologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthobiologics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Orthobiologics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Orthobiologics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Orthobiologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Viscosupplements
- Bone Graft Substitute
- Bone Growth Stimulators (BGS)
Applications
- Hospitals
- Ambulatory Surgical Centres
- Orthopaedics Clinics
Companies covered
- Stryker Corporation
- Sanofi-Aventis (Sanofi SA)
- Medtronic
- Zimmer Biomet Holdings
- TRB Chemedica International SA
- Seikagaku Corporation
- SeaSpine Holdings Corporation
- RTI Surgical, Inc.
- Orthofix International N.V.
- NuVasive, Inc.
- Musculoskeletal Transplant Foundation, Inc.
- Ito
- Heraeus Holding GmbH
- Fidia Pharma USA Inc.
- Djo Global, Inc.
- DePuy Synthes (Johnson & Johnson)
- Bioventus
- Arthrex, Inc.
- Anika Therapeutics, Inc.
- Allosource
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Orthobiologics Market Size (2021-2032)
- 2.2.2 Global Orthobiologics Sales (2021-2032)
- 2.2.3 Global Orthobiologics Market Average Price (2021-2032)
- 2.3 Orthobiologics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Viscosupplements
- 2.3.3 Bone Graft Substitute
- 2.3.4 Bone Growth Stimulators (BGS)
- 2.4 Orthobiologics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Ambulatory Surgical Centres
- 2.4.4 Orthopaedics Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Orthobiologics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Orthobiologics Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Orthobiologics Revenue of Manufacturers (2021-2026)
- 3.4 Global Orthobiologics Average Price by Manufacturers (2021-2026)
- 3.5 Global Orthobiologics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Orthobiologics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Orthobiologics, Product Type & Application
- 3.8 Global Manufacturers of Orthobiologics, Established Date
- 3.9 Global Orthobiologics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Stryker Corporation
- 4.1.1 Stryker Corporation Company Information
- 4.1.2 Stryker Corporation Business Overview
- 4.1.3 Stryker Corporation Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Stryker Corporation Orthobiologics Product Portfolio
- 4.1.5 Stryker Corporation Recent Developments
- 4.2 Sanofi-Aventis (Sanofi SA)
- 4.2.1 Sanofi-Aventis (Sanofi SA) Company Information
- 4.2.2 Sanofi-Aventis (Sanofi SA) Business Overview
- 4.2.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolio
- 4.2.5 Sanofi-Aventis (Sanofi SA) Recent Developments
- 4.3 Medtronic
- 4.3.1 Medtronic Company Information
- 4.3.2 Medtronic Business Overview
- 4.3.3 Medtronic Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Medtronic Orthobiologics Product Portfolio
- 4.3.5 Medtronic Recent Developments
- 4.4 Zimmer Biomet Holdings
- 4.4.1 Zimmer Biomet Holdings Company Information
- 4.4.2 Zimmer Biomet Holdings Business Overview
- 4.4.3 Zimmer Biomet Holdings Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zimmer Biomet Holdings Orthobiologics Product Portfolio
- 4.4.5 Zimmer Biomet Holdings Recent Developments
- 4.5 TRB Chemedica International SA
- 4.5.1 TRB Chemedica International SA Company Information
- 4.5.2 TRB Chemedica International SA Business Overview
- 4.5.3 TRB Chemedica International SA Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TRB Chemedica International SA Orthobiologics Product Portfolio
- 4.5.5 TRB Chemedica International SA Recent Developments
- 4.6 Seikagaku Corporation
- 4.6.1 Seikagaku Corporation Company Information
- 4.6.2 Seikagaku Corporation Business Overview
- 4.6.3 Seikagaku Corporation Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Seikagaku Corporation Orthobiologics Product Portfolio
- 4.6.5 Seikagaku Corporation Recent Developments
- 4.7 SeaSpine Holdings Corporation
- 4.7.1 SeaSpine Holdings Corporation Company Information
- 4.7.2 SeaSpine Holdings Corporation Business Overview
- 4.7.3 SeaSpine Holdings Corporation Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 SeaSpine Holdings Corporation Orthobiologics Product Portfolio
- 4.7.5 SeaSpine Holdings Corporation Recent Developments
- 4.8 RTI Surgical, Inc.
- 4.8.1 RTI Surgical, Inc. Company Information
- 4.8.2 RTI Surgical, Inc. Business Overview
- 4.8.3 RTI Surgical, Inc. Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 RTI Surgical, Inc. Orthobiologics Product Portfolio
- 4.8.5 RTI Surgical, Inc. Recent Developments
- 4.9 Orthofix International N.V.
- 4.9.1 Orthofix International N.V. Company Information
- 4.9.2 Orthofix International N.V. Business Overview
- 4.9.3 Orthofix International N.V. Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Orthofix International N.V. Orthobiologics Product Portfolio
- 4.9.5 Orthofix International N.V. Recent Developments
- 4.10 NuVasive, Inc.
- 4.10.1 NuVasive, Inc. Company Information
- 4.10.2 NuVasive, Inc. Business Overview
- 4.10.3 NuVasive, Inc. Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 NuVasive, Inc. Orthobiologics Product Portfolio
- 4.10.5 NuVasive, Inc. Recent Developments
- 4.11 Musculoskeletal Transplant Foundation, Inc.
- 4.11.1 Musculoskeletal Transplant Foundation, Inc. Company Information
- 4.11.2 Musculoskeletal Transplant Foundation, Inc. Business Overview
- 4.11.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolio
- 4.11.5 Musculoskeletal Transplant Foundation, Inc. Recent Developments
- 4.12 Ito
- 4.12.1 Ito Company Information
- 4.12.2 Ito Business Overview
- 4.12.3 Ito Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ito Orthobiologics Product Portfolio
- 4.12.5 Ito Recent Developments
- 4.13 Heraeus Holding GmbH
- 4.13.1 Heraeus Holding GmbH Company Information
- 4.13.2 Heraeus Holding GmbH Business Overview
- 4.13.3 Heraeus Holding GmbH Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Heraeus Holding GmbH Orthobiologics Product Portfolio
- 4.13.5 Heraeus Holding GmbH Recent Developments
- 4.14 Fidia Pharma USA Inc.
- 4.14.1 Fidia Pharma USA Inc. Company Information
- 4.14.2 Fidia Pharma USA Inc. Business Overview
- 4.14.3 Fidia Pharma USA Inc. Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Fidia Pharma USA Inc. Orthobiologics Product Portfolio
- 4.14.5 Fidia Pharma USA Inc. Recent Developments
- 4.15 Djo Global, Inc.
- 4.15.1 Djo Global, Inc. Company Information
- 4.15.2 Djo Global, Inc. Business Overview
- 4.15.3 Djo Global, Inc. Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Djo Global, Inc. Orthobiologics Product Portfolio
- 4.15.5 Djo Global, Inc. Recent Developments
- 4.16 DePuy Synthes (Johnson & Johnson)
- 4.16.1 DePuy Synthes (Johnson & Johnson) Company Information
- 4.16.2 DePuy Synthes (Johnson & Johnson) Business Overview
- 4.16.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolio
- 4.16.5 DePuy Synthes (Johnson & Johnson) Recent Developments
- 4.17 Bioventus
- 4.17.1 Bioventus Company Information
- 4.17.2 Bioventus Business Overview
- 4.17.3 Bioventus Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Bioventus Orthobiologics Product Portfolio
- 4.17.5 Bioventus Recent Developments
- 4.18 Arthrex, Inc.
- 4.18.1 Arthrex, Inc. Company Information
- 4.18.2 Arthrex, Inc. Business Overview
- 4.18.3 Arthrex, Inc. Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Arthrex, Inc. Orthobiologics Product Portfolio
- 4.18.5 Arthrex, Inc. Recent Developments
- 4.19 Anika Therapeutics, Inc.
- 4.19.1 Anika Therapeutics, Inc. Company Information
- 4.19.2 Anika Therapeutics, Inc. Business Overview
- 4.19.3 Anika Therapeutics, Inc. Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Anika Therapeutics, Inc. Orthobiologics Product Portfolio
- 4.19.5 Anika Therapeutics, Inc. Recent Developments
- 4.20 Allosource
- 4.20.1 Allosource Company Information
- 4.20.2 Allosource Business Overview
- 4.20.3 Allosource Orthobiologics Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Allosource Orthobiologics Product Portfolio
- 4.20.5 Allosource Recent Developments
5 Global Orthobiologics Market Scenario by Region
- 5.1 Global Orthobiologics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Orthobiologics Sales by Region: 2021-2032
- 5.2.1 Global Orthobiologics Sales by Region: 2021-2026
- 5.2.2 Global Orthobiologics Sales by Region: 2027-2032
- 5.3 Global Orthobiologics Revenue by Region: 2021-2032
- 5.3.1 Global Orthobiologics Revenue by Region: 2021-2026
- 5.3.2 Global Orthobiologics Revenue by Region: 2027-2032
- 5.4 North America Orthobiologics Market Facts & Figures by Country
- 5.4.1 North America Orthobiologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Orthobiologics Sales by Country (2021-2032)
- 5.4.3 North America Orthobiologics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Orthobiologics Market Facts & Figures by Country
- 5.5.1 Europe Orthobiologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Orthobiologics Sales by Country (2021-2032)
- 5.5.3 Europe Orthobiologics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Orthobiologics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Orthobiologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Orthobiologics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Orthobiologics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Orthobiologics Market Facts & Figures by Country
- 5.7.1 South America Orthobiologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Orthobiologics Sales by Country (2021-2032)
- 5.7.3 South America Orthobiologics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Orthobiologics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Orthobiologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Orthobiologics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Orthobiologics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Orthobiologics Sales by Type (2021-2032)
- 6.1.1 Global Orthobiologics Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Orthobiologics Sales Market Share by Type (2021-2032)
- 6.2 Global Orthobiologics Revenue by Type (2021-2032)
- 6.2.1 Global Orthobiologics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Orthobiologics Revenue Market Share by Type (2021-2032)
- 6.3 Global Orthobiologics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Orthobiologics Sales by Application (2021-2032)
- 7.1.1 Global Orthobiologics Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Orthobiologics Sales Market Share by Application (2021-2032)
- 7.2 Global Orthobiologics Revenue by Application (2021-2032)
- 7.2.1 Global Orthobiologics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Orthobiologics Revenue Market Share by Application (2021-2032)
- 7.3 Global Orthobiologics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Orthobiologics Value Chain Analysis
- 8.1.1 Orthobiologics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Orthobiologics Production Mode & Process
- 8.2 Orthobiologics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Orthobiologics Distributors
- 8.2.3 Orthobiologics Customers
9 Global Orthobiologics Analyzing Market Dynamics
- 9.1 Orthobiologics Industry Trends
- 9.2 Orthobiologics Industry Drivers
- 9.3 Orthobiologics Industry Opportunities and Challenges
- 9.4 Orthobiologics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst